Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryant G Darnay

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Genes & Development|April 18, 2007
CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activationBrian C Grabiner, Marzenna Blonska, Pei-Chun Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2009
A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chainsMichael Düwel, Verena Welteke, Andrea Oeckinghaus, et al.
Cancer Research|November 17, 2006
Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGelKhalid A Mohamedali, Ann T Poblenz, Charles R Sikes, et al.
Plos One|September 10, 2008
Cthrc1 is a positive regulator of osteoblastic bone formationHiroaki Kimura, Kin Ming Kwan, Zhaoping Zhang, et al.
The EMBO Journal|March 17, 2007
Phosphorylation and ubiquitination of the IkappaB kinase complex by two distinct signaling pathwaysPrashant B Shambharkar, Marzenna Blonska, Bhanu P Pappu, et al.
Journal of Molecular Biology|January 1, 2008
Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20Su-Chang Lin, Jee Y Chung, Betty Lamothe, et al.
Oncotarget|December 10, 2013
A TRAF2 binding independent region of TNFR2 is responsible for TRAF2 depletion and enhancement of cytotoxicity driven by TNFR1Lucía Cabal-Hierro, Noelia Artime, Julián Iglesias, et al.
Cancer Biology & Therapy|October 27, 2009
Dasatinib inhibits both osteoclast activation and prostate cancer PC-3-cell-induced osteoclast formationJohn C Araujo, Ann Poblenz, Paul Corn, et al.
The Journal of Biological Chemistry|December 21, 2007
Nuclear tumor necrosis factor receptor-associated factor 6 in lymphoid cells negatively regulates c-Myb-mediated transactivation through small ubiquitin-related modifier-1 modificationLan V Pham, Hai-Jun Zhou, Yen-Chiu Lin-Lee, et al.
Journal of the National Cancer Institute|June 26, 2008
Association between imatinib-resistant BCR-ABL mutation-negative leukemia and persistent activation of LYN kinaseJi Wu, Feng Meng, Ling-Yuan Kong, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Genes & Development|April 18, 2007
CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activationBrian C Grabiner, Marzenna Blonska, Pei-Chun Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2009
A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chainsMichael Düwel, Verena Welteke, Andrea Oeckinghaus, et al.
Cancer Research|November 17, 2006
Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGelKhalid A Mohamedali, Ann T Poblenz, Charles R Sikes, et al.
Plos One|September 10, 2008
Cthrc1 is a positive regulator of osteoblastic bone formationHiroaki Kimura, Kin Ming Kwan, Zhaoping Zhang, et al.
The EMBO Journal|March 17, 2007
Phosphorylation and ubiquitination of the IkappaB kinase complex by two distinct signaling pathwaysPrashant B Shambharkar, Marzenna Blonska, Bhanu P Pappu, et al.
Journal of Molecular Biology|January 1, 2008
Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20Su-Chang Lin, Jee Y Chung, Betty Lamothe, et al.
Oncotarget|December 10, 2013
A TRAF2 binding independent region of TNFR2 is responsible for TRAF2 depletion and enhancement of cytotoxicity driven by TNFR1Lucía Cabal-Hierro, Noelia Artime, Julián Iglesias, et al.
Cancer Biology & Therapy|October 27, 2009
Dasatinib inhibits both osteoclast activation and prostate cancer PC-3-cell-induced osteoclast formationJohn C Araujo, Ann Poblenz, Paul Corn, et al.
The Journal of Biological Chemistry|December 21, 2007
Nuclear tumor necrosis factor receptor-associated factor 6 in lymphoid cells negatively regulates c-Myb-mediated transactivation through small ubiquitin-related modifier-1 modificationLan V Pham, Hai-Jun Zhou, Yen-Chiu Lin-Lee, et al.
Journal of the National Cancer Institute|June 26, 2008
Association between imatinib-resistant BCR-ABL mutation-negative leukemia and persistent activation of LYN kinaseJi Wu, Feng Meng, Ling-Yuan Kong, et al.
Pageof 4